
PDL BioPharma (PDLI)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy PDL BioPharma (PDLI) Stock
Start investing in PDL BioPharma (PDLI)
About PDL BioPharma (PDLI)
Market cap | $233.85M |
Today's volume | — |
Revenue (TTM) | — |
Avg. daily volume | 2.3M |
EBITDA (TTM) | — |
Open | — |
Price / earnings ratio | -1.81x |
Today's range | — |
Debt / equity | — |
52 week range | $1.61 - $2.52 |
5 year debt / equity | — |
Beta (LTM) | 0.76x |
Interest coverage | — |
Dividend & yield | $0.00 (0.00%) |
Current ratio | — |
Ex-dividend date | — |
Next earnings | Nov 11, 2020 |
Dividend payable date | — |
PDL BioPharma Stock News
View all



Frequently Asked Questions (FAQ)
How to buy PDLI stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in PDLI stock
Navigate to the Explore page. Then, type PDLI into the search bar. When you see PDLI stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased PDLI stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
PDL BioPharma Stock Earnings
The value each PDLI share was expected to gain vs. the value that each PDLI share actually gained.
PDL BioPharma (PDLI) reported Q3 2020 earnings per share (EPS) of -$0.10, missing estimates of $0.06 by 266.67%. In the same quarter last year, PDL BioPharma's earnings per share (EPS) was $0. PDL BioPharma is expected to release next earnings on 11/11/2020, with an earnings per share (EPS) estimate of $0.